NCT02174237View on ClinicalTrials.gov

A Study to Test the Safety/Tolerability of Increasing Doses of LNP1892 Versus Placebo in Healthy Male/Female Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions

Healthy

Interventions

DRUG

LNP1892

Tablets of two strengths (5 and 25 mg)

DRUG

Placebo

Matching placebo

Trial Locations (1)

LS2 9LH

Covance Clinical Research Unit Ltd. Springfield House Hyde Street, Leeds

All Listed Sponsors

lead

Lupin Ltd.

INDUSTRY

NCT02174237 - A Study to Test the Safety/Tolerability of Increasing Doses of LNP1892 Versus Placebo in Healthy Male/Female Subjects | Biotech Hunter | Biotech Hunter